A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European region.
about
Targeted therapy of gastrointestinal stromal tumoursEfficacy of Imatinib in Patients with Platelet-Derived Growth Factor Receptor Alpha-Mutated Gastrointestinal Stromal Tumors.Current management and prognostic features for gastrointestinal stromal tumor (GIST)Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testingUK clinical practice guidelines for the management of gastrointestinal stromal tumours (GIST).Characterization and assessment of the sensitivity and resistance of a newly established human gastrointestinal stromal tumour xenograft model to treatment with tyrosine kinase inhibitors.Survival of gastrointestinal stromal tumor patients in the imatinib era: life raft group observational registry.Preoperative imatinib for patients with primary unresectable or metastatic/recurrent gastrointestinal stromal tumor.Gene expression patterns of hemizygous and heterozygous KIT mutations suggest distinct oncogenic pathways: a study in NIH3T3 cell lines and GIST samples.Gastrointestinal stromal tumors, somatic mutations and candidate genetic risk variantsFrequence, spectrum and prognostic impact of additional malignancies in patients with gastrointestinal stromal tumors.Correlation between mutational status and survival and second cancer risk assessment in patients with gastrointestinal stromal tumors: a population-based study.Association of high expression of Groβ with clinical and pathological characteristics of unfavorable prognosis in gastrointestinal stromal tumors.Copy-neutral loss of heterozygosity and chromosome gains and losses are frequent in gastrointestinal stromal tumors.Synchronous occurrence of gastrointestinal stromal tumors and other digestive tract malignancies in the elderly.KIT exon 10 variant (c.1621 A > C) single nucleotide polymorphism as predictor of GIST patient outcome.Presence of PDGFRA and DOG1 mutations in gastrointestinal stromal tumors among Chinese population.Pathology of gastrointestinal stromal tumors.Endoscopic versus open resection for small gastric gastrointestinal stromal tumors: safety and outcomesExtended adjuvant therapy with imatinib in patients with gastrointestinal stromal tumors : recommendations for patient selection, risk assessment, and molecular response monitoring.Surgical treatment of gastric gastrointestinal stromal tumorBlood neutrophil-to-lymphocyte ratio is prognostic in gastrointestinal stromal tumor.Gastrointestinal stromal tumors: a case-only analysis of single nucleotide polymorphisms and somatic mutations.Comparison of Different Risk Classification Systems in 558 Patients with Gastrointestinal Stromal Tumors after R0-Resection.Gastric polyps: a review of clinical, endoscopic, and histopathologic features and management decisions.Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST).Gastrointestinal stromal tumors: what do we know now?Systemic treatment of soft-tissue sarcoma-gold standard and novel therapies.Metastatic Liver Disease Associated with Gastrointestinal Stromal Tumors: Controversies in Diagnostic and Therapeutic Approach.Clinical activity of regorafenib in PDGFRA-mutated gastrointestinal stromal tumor.Rectal gastrointestinal stromal tumor with metastasis to the penis: Case report and review of literature.Effects of endoplasmic reticulum stressors on maturation and signaling of hemizygous and heterozygous wild-type and mutant forms of KIT.[Gastrointestinal stromal tumors (GIST): at the forefront of targeted therapies].Imatinib response of gastrointestinal stromal tumor patients with germline mutation on KIT exon 13: A family report.The incidence, mutational status, risk classification and referral pattern of gastro-intestinal stromal tumours in the Netherlands: a nationwide pathology registry (PALGA) study.Contrast-enhanced endoscopic ultrasonography can predict a higher malignant potential of gastrointestinal stromal tumors by visualizing large newly formed vessels.Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of KIT/PDGFRA genes and novel genomic alterations: results from a 20-year cohort of patients with GIST from north-western Greece.Surgical treatment of gastrointestinal stromal tumour of the rectum in the era of imatinib.Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTsClinicopathological characteristics and prognostic factors of gastrointestinal stromal tumors in Chinese patients
P2860
Q26745633-E04B69B9-5582-41D4-9304-7C7ED21340BEQ27853181-CE9CD013-6067-4134-A914-E6F1C27DE817Q28391684-0C91CF54-1CD7-4922-9609-302B495527CDQ28741842-E17F3DE5-1325-47BB-B551-6D42731DD963Q33612778-850879E6-D2FC-492C-BB79-72723062E28BQ34052411-D6668FC7-DAC3-4689-9615-FE54E77A60AAQ34202009-7ED6738C-7F95-4B58-B7E1-08A826EC4E67Q34628804-69ADCDB9-1DA6-4E23-BF3A-3CDBF2A01E6DQ34674610-9B8695BA-79B8-4268-B552-CD7C8AA3C572Q34700954-CD9E5749-B80D-489F-A455-3AB36A9D8FEBQ35024075-7728A9FB-74A4-4E02-9788-2032AD591BB1Q35108718-6EC47C77-83EF-4CBA-AFD0-1A69CAF49502Q35511907-FDBD6B48-9862-479B-9815-CF3D2503B7FEQ35562510-03F0B381-893D-46E6-8820-B6F91EF4DFA2Q35781609-6B9DE8B3-9751-45CE-8AAD-F4C327A36B50Q35820278-E7F3330D-F5EE-439D-94FF-BDA199879661Q35854357-1176C203-A1A2-425A-B9F7-8471F959D7FCQ36129663-6FB04024-C240-41DE-86B7-6F2E200EA48CQ36152805-D30CC6F7-5433-4BA8-81E6-246521A4F1A8Q36589296-574C4253-59AB-401E-BA7D-1789BB074F7EQ36770203-C7F1C353-BCB5-49B9-AA93-1155C524F043Q36979386-D54D6253-CE40-4794-8DC7-FD2F15E0EACEQ37308195-74F57D70-75F8-45A0-BC16-1E6667C870C6Q37533115-A55F3E27-3E8D-4616-AF5D-840EF393E559Q37710788-D168FFB4-1DB2-4A5C-BE25-218016492DE9Q37747750-63C3D268-58DF-43CE-BB49-B8EF7020CE74Q38175310-7A132C1C-AF2F-4A93-8AC3-EC4EDA0BD95EQ38197031-71B9556A-2BAD-496C-B920-618931FDEECDQ38545069-4C8131D9-DC2F-4578-9533-4B533996BC65Q38776931-52825166-FBF7-42FD-A332-9859A9E470FDQ39013962-F1C06FCD-2D22-4951-8D1E-F2F0A8723137Q41134667-AEDEE0DE-5B1F-470B-BEBC-9E3604D9DE3CQ45964404-3CB58CF1-4748-48D6-905F-563C73E08E75Q46050387-7760A1B1-DB8B-4F9D-B5F9-6C7E33007701Q50142125-64FC70A3-E4A6-4B7F-99AA-A7FEC6977F2EQ53059339-41221505-4875-4609-B1A9-59DBCA50460CQ54116611-A18A8107-2ED5-4DF1-A775-1C6CD4FAA499Q55059101-B7EE705C-86D1-4B6A-9E43-7AB30C91C499Q57570822-38C9CA85-18C4-4150-BC68-F3A7774400C0Q58767664-16C4D856-49E9-49E8-9154-16C42BB5FA3C
P2860
A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European region.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A prospective epidemiological ...... of GIST in a European region.
@ast
A prospective epidemiological ...... of GIST in a European region.
@en
A prospective epidemiological ...... of GIST in a European region.
@nl
type
label
A prospective epidemiological ...... of GIST in a European region.
@ast
A prospective epidemiological ...... of GIST in a European region.
@en
A prospective epidemiological ...... of GIST in a European region.
@nl
prefLabel
A prospective epidemiological ...... of GIST in a European region.
@ast
A prospective epidemiological ...... of GIST in a European region.
@en
A prospective epidemiological ...... of GIST in a European region.
@nl
P2093
P2860
P356
P1476
A prospective epidemiological ...... of GIST in a European region.
@en
P2093
A-V Decouvelaere
D Ranchère-Vince
F Ducimetière
J-Y Scoazec
P A Cassier
P-P Bringuier
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605743
P407
P577
2010-06-29T00:00:00Z
P5875
P6179
1004083662